Tag: Biogen

  • Biogen Explodes on Game-Changing Alzheimer’s News

    Biogen Explodes on Game-Changing Alzheimer’s News

    Shares of Biogen (BBIB) are up more than $93 in pre-market. All after a substantial announcement on its Alzheimer’s drug study, in partnership with Eisai. In fact, “The two pharma companies said their drug lecanemab reduced cognitive and functional decline by 27% relative to a placebo. The findings come over an 18 month stretch in…